Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422

Watchlist Manager
Sichuan Kelun Pharmaceutical Co Ltd Logo
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Watchlist
Price: 30.6 CNY -7.66% Market Closed
Market Cap: 46.9B CNY
Have any thoughts about
Sichuan Kelun Pharmaceutical Co Ltd?
Write Note

Sichuan Kelun Pharmaceutical Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sichuan Kelun Pharmaceutical Co Ltd
Accounts Receivables Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Accounts Receivables
ÂĄ4.7B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
7%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accounts Receivables
ÂĄ3.2B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accounts Receivables
ÂĄ809.6m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
14%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accounts Receivables
ÂĄ6.2B
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accounts Receivables
ÂĄ10.1B
CAGR 3-Years
21%
CAGR 5-Years
36%
CAGR 10-Years
28%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accounts Receivables
ÂĄ98.4m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sichuan Kelun Pharmaceutical Co Ltd's Accounts Receivables?
Accounts Receivables
4.7B CNY

Based on the financial report for Jun 30, 2024, Sichuan Kelun Pharmaceutical Co Ltd's Accounts Receivables amounts to 4.7B CNY.

What is Sichuan Kelun Pharmaceutical Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
7%

Over the last year, the Accounts Receivables growth was -15%. The average annual Accounts Receivables growth rates for Sichuan Kelun Pharmaceutical Co Ltd have been -5% over the past three years , -6% over the past five years , and 7% over the past ten years .

Back to Top